Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Transplantation Proceedings|January 10, 2022
Sirolimus-Induced Pulmonary Alveolar Proteinosis in the Context of Hematopoietic Stem Cells Transplant Rejection: A Case ReportLaura Marchasson, Julien Dutilh, Stéphane Jouneau, et al.
Presse Medicale (Paris, France : 1983)|April 25, 2017
[Continuous positive airway pressure in obstructive sleep apnea]Jean Claude Meurice, Elise Antone, Mylene Gilbert, et al.
La Revue De Medecine Interne|July 3, 2024
Screening for primary immune deficiency among patients with bronchiectasisMylène Dufrénoy, Luminita Luca, Vanessa Bironneau, et al.
Fundamental & Clinical Pharmacology|May 27, 2025
Vitamin D lacks efficacy: A re-analysis of a systematic review using the REB methodVanessa Bironneau, Marie Laura Palamede, Elodie Charuel, et al.
Respiratory Care|October 27, 2021
<i>β</i> Agonist Delivery by High-Flow Nasal Cannula During COPD ExacerbationClément Beuvon, Rémi Coudroy, Justine Bardin, et al.
Respiratory Medicine and Research|May 3, 2025
Pulmonary Arterial Hypertension-approved drugs in Pulmonary Hypertension associated with COPD: A systematic literature reviewBeatrice Le Bon Chami, Fida Charif, Claude Semaan, et al.
Respiratory Care|May 30, 2023
Sleep Assessment in Critically Ill Patients With Acute Hypoxemic Respiratory FailureArnaud W Thille, Damien Marie, Faustine Reynaud, et al.
The Journal of Nutrition|April 17, 2018
Polyphenols Have No Impact on Endothelial Function in Patients with Obstructive Sleep Apnea: A Randomized Controlled TrialWojciech Trzepizur, Vanessa Bironneau, Sylvain Recoquillon, et al.
Critical Care (London, England)|October 10, 2024
Impact of sleep disturbances on outcomes in intensive care unitsLaura Marchasson, Christophe Rault, Sylvain Le Pape, et al.
The Lancet. Infectious Diseases|February 4, 2021
Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trialJérémy Guenezan, Nicolas Marjanovic, Bertrand Drugeon, et al.
Pageof 3